Literature DB >> 23362145

Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells.

Zhaosha Li1, J Kar Kruijt, Ronald J van der Sluis, Theo J C Van Berkel, Menno Hoekstra.   

Abstract

The liver consists of different cell types that together synchronize crucial roles in liver homeostasis. Since nuclear receptors constitute an important class of drug targets that are involved in a wide variety of physiological processes, we have composed the hepatic cell type-specific expression profile of nuclear receptors to uncover the pharmacological potential of liver-enriched nuclear receptors. Parenchymal liver cells (hepatocytes) and liver endothelial and Kupffer cells were isolated from virgin female C57BL/6 wild-type mice using collagenase perfusion and counterflow centrifugal elutriation. The hepatic expression pattern of 49 nuclear receptors was generated by real-time quantitative PCR using the NUclear Receptor Signaling Atlas (NURSA) program resources. Thirty-six nuclear receptors were expressed in total liver. FXR-α, EAR2, LXR-α, HNF4-α, and CAR were the most abundantly expressed nuclear receptors in liver parenchymal cells. In contrast, NUR77, COUP-TFII, LXR-α/β, FXR-α, and EAR2 were the most highly expressed nuclear receptors in endothelial and Kupffer cells. Interestingly, members of orphan receptor COUP-TF family showed a distinct expression pattern. EAR2 was highly and exclusively expressed in parenchymal cells, while COUP-TFII was moderately and exclusively expressed in endothelial and Kupffer cells. Of interest, the orphan receptor TR4 showed a similar expression pattern as the established lipid sensor PPAR-γ. In conclusion, our study provides the most complete quantitative assessment of the nuclear receptor distribution in liver reported to date. Our gene expression catalog suggests that orphan nuclear receptors such as COUP-TFII, EAR2, and TR4 may be of significant importance as novel targets for pharmaceutical interventions in liver.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362145     DOI: 10.1152/physiolgenomics.00151.2012

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  13 in total

Review 1.  Gut Microbiota of Nonalcoholic Fatty Liver Disease.

Authors:  Reham M Abdou; Lixin Zhu; Robert D Baker; Susan S Baker
Journal:  Dig Dis Sci       Date:  2016-02-22       Impact factor: 3.199

Review 2.  Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.

Authors:  Weinan Zhou; Sayeepriyadarshini Anakk
Journal:  Mol Cell Endocrinol       Date:  2022-03-15       Impact factor: 4.369

3.  Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis.

Authors:  April D Lake; Alexandria L Chaput; Petr Novak; Nathan J Cherrington; Catharine L Smith
Journal:  Biochem Pharmacol       Date:  2016-11-09       Impact factor: 5.858

4.  Cyclosporin A induced toxicity in mouse liver slices is only slightly aggravated by Fxr-deficiency and co-occurs with upregulation of pro-inflammatory genes and downregulation of genes involved in mitochondrial functions.

Authors:  Ewa Szalowska; Tessa E Pronk; Ad Acm Peijnenburg
Journal:  BMC Genomics       Date:  2015-10-20       Impact factor: 3.969

5.  Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.

Authors:  Ewa Szalowska; Haftu A Tesfay; Sacha A F T van Hijum; Sander Kersten
Journal:  BMC Genomics       Date:  2014-12-15       Impact factor: 3.969

6.  Transcriptomic Analysis of Hepatic Cells in Multicellular Organotypic Liver Models.

Authors:  Allison N Tegge; Richard R Rodrigues; Adam L Larkin; Lucas Vu; T M Murali; Padmavathy Rajagopalan
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

7.  Retinoids Issued from Hepatic Stellate Cell Lipid Droplet Loss as Potential Signaling Molecules Orchestrating a Multicellular Liver Injury Response.

Authors:  Marie Bobowski-Gerard; Francesco Paolo Zummo; Bart Staels; Philippe Lefebvre; Jérôme Eeckhoute
Journal:  Cells       Date:  2018-09-13       Impact factor: 6.600

Review 8.  The Nuclear Receptor PXR in Chronic Liver Disease.

Authors:  Katia Sayaf; Ilaria Zanotto; Francesco Paolo Russo; Daniela Gabbia; Sara De Martin
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

9.  FXR controls CHOP expression in steatohepatitis.

Authors:  Claudia D Fuchs; Thierry Claudel; Hubert Scharnagl; Tatjana Stojakovic; Michael Trauner
Journal:  FEBS Lett       Date:  2017-10-11       Impact factor: 4.124

Review 10.  Regulation of CAR and PXR Expression in Health and Disease.

Authors:  Martine Daujat-Chavanieu; Sabine Gerbal-Chaloin
Journal:  Cells       Date:  2020-10-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.